Tue. Jul 23rd, 2024

ICMR, NIV initiate phase-3 clinical trials of recombinant dengue vax: Centre

By Vaseline May30,2024
ICMR, NIV initiate phase-3 clinical trials of recombinant dengue vax: Centre

NEW DELHI: ICMR, NIV initiate phase-3 clinical trials of recombinant dengue vax: Centre

New Delhi, May 29 (IANS) The Indian Council of Medical Research (ICMR) along with the Pune-based National Institute of Virology (NIV) and other research institutes will launch phase-3 clinical trials of the recombinant dengue vaccine, Apurva Chandra said , Union Health Minister, Wednesday.

He said this while addressing the meeting of health ministers of BRICS (Brazil, Russia, India, China and South Africa) on the sidelines of the 77th World Health Assembly (WHA) of the World Health Organization (WHO) in Geneva.

The Health Minister said that the BRICS Vaccine Research and Development Center was launched virtually during the Presidency of India in March 2022.

“India has demonstrated active engagement in BRICS healthcare initiatives, promoting joint efforts to advance joint health agendas aimed at strengthening healthcare systems in the BRICS countries, thereby addressing critical global health challenges suit,” said Chandra.

“ICMR, along with NIV and a network of other partner institutes, is embarking on phase-3 clinical trials of recombinant dengue vaccine.”

“In addition, ICMR and other partners will also work on research and trials for locally endemic diseases such as Kyasanur Forest Disease (KFD), Nipah virus, Human Papillomavirus, MTBVAC (Mycobacterium Tuberculosis Vaccine) and influenza,” he added.

Further, Chandra noted that India’s National Action Plan against AMR, launched in 2017, is in line with the objectives set out in the WHO’s Global Action Plan on Antimbiotic Resistance (AMR).

“India recognizes AMR as a global concern and advocates promoting cooperation among BRICS countries to devise and implement protocols, projects and platforms to tackle AMR,” the Union Health Minister said.

He noted that “India recognizes the importance of promoting cooperation within the BRICS countries in the field of nuclear medicine and radiopharmaceutical science”.

The country also aims to “strengthen the radiopharmaceutical supply chain and improve isotope production, in addition to promoting the development and commercialization of advanced digital solutions,” he added.

Chandra urged member states to enhance cooperation and work together to find solutions to various health challenges.



Related Post